News & Events
PRESS RELEASE: Optellum Appoints Jason Pesterfield as CEO to Drive Commercial Growth in the USA
Fast-growing lung-health AI startup strengthens executive team with business leader experienced in medical devices for lung cancer diagnosis. Jason Pesterfield ...
Read More
Read More
PRESS RELEASE: Optellum Announces Strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson, Applying AI to Transform Early Lung Cancer Treatment
Rapidly growing lung health startup aims to redefine early interception of lung cancer using artificial intelligence (AI) decision support software ...
Read More
Read More
AI software could help clinicians diagnose lung cancer earlier and reduce waiting lists for patients
A new artificial intelligence software that will help doctors to make quicker and more accurate decisions when diagnosing potentially cancerous ...
Read More
Read More
European consortium validates Optellum AI to differentiate between benign and malignant lung nodules in a multi-center study
A paper published in Lung Cancer demonstrates the ability of Optellum’s Lung Cancer Prediction artificial intelligence (AI) to classify lung ...
Read More
Read More
Sam Janes to present to ASCO annual meeting 4-8 June
Professor Sam Janes, a leading clinician and University College London academic will presenting a poster to American Society of Clinical Oncology (ASCO) annual meeting ...
Read More
Read More
Webinar: Dr Vachani and Dr Bellinger discuss AI for lung cancer diagnosis
Join us on June 23rd at 1pm EST for a webinar where expert clinical speakers will discuss the evidence, clinically-validated ...
Read More
Read More
NCIMI voices podcast: AI and lung health
The National Consortium of Intelligent Medical Imaging (NCIMI) podcast provides expert insights on the future of #AI in healthcare. In ...
Read More
Read More
Optellum in the news
Optellum was in the UK national news this week with coverage from the BBC and the i newspaper, among others ...
Read More
Read More
PRESS RELEASE: UK health tech company, goes global with breakthrough in early lung cancer diagnosis AI technology
Oxford-based company Optellum, supported by NHS collaborations and grant funding, launches the world’s first AI decision support for early lung ...
Read More
Read More
Patients and physicians benefit from Optellum’s Virtual Nodule Clinic
Optellum is excited to be working with a leading hospital on the first clinical installation of Virtual Nodule Clinic (VNC) ...
Read More
Read More
Optellum’s AI could speed up lung cancer screening by detecting benign perifissural lung nodules
Optellum has been collaborating with Oxford University Hospitals and UMC Groningen to evaluate the ability of our AI to assist ...
Read More
Read More
US PRESS RELEASE: Optellum Receives FDA Clearance for the World’s First AI-Powered Clinical Decision Support Software for Early Lung Cancer Diagnosis
Virtual Nodule Clinic empowers clinicians to make optimal clinical decisions in early-stage lung cancer diagnosis and is now commercially available ...
Read More
Read More
